First Header Logo Second Header Logo

Connection

Michael Shapiro to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Michael Shapiro has written about Clinical Trials, Phase III as Topic.
Michael Shapiro
Connection Strength
0.179
Clinical Trials, Phase III as Topic
  1. Mahmood T, Minnier J, Ito MK, Li QH, Koren A, Kam IW, Fazio S, Shapiro MD. Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies. Eur J Prev Cardiol. 2021 Jul 23; 28(8):816-822.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.